[P02BB01, trichlorfon, Metrifonate may increase the neuromuscular blocking activities of Cocaine.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Cocaine.]
[J01GA01, streptomycin, The risk or severity of methemoglobinemia can be increased when Streptomycin is combined with Cocaine.]
[L01AD04, streptozocin, The risk or severity of methemoglobinemia can be increased when Streptozocin is combined with Cocaine.]
[M03AB01, succinylcholine, Succinylcholine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01CA16, sulbenicillin, The risk or severity of methemoglobinemia can be increased when Sulbenicillin is combined with Cocaine.]
[S01AB04, sulfacetamide, The risk or severity of methemoglobinemia can be increased when Sulfacetamide is combined with Cocaine.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Cocaine.]
[J01ED07, sulfamerazine, The risk or severity of methemoglobinemia can be increased when Sulfamerazine is combined with Cocaine.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Cocaine.]
[J01ED05, sulfamethoxypyridazine, The risk or severity of methemoglobinemia can be increased when Sulfamethoxypyridazine is combined with Cocaine.]
[J01EB06, sulfanilamide, The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Cocaine.]
[S01AB02, sulfisoxazole, The risk or severity of methemoglobinemia can be increased when Sulfisoxazole is combined with Cocaine.]
[N05AL01, sulpiride, Cocaine may increase the anticholinergic activities of Sulpiride.]
[N03AX03, sulthiame, The risk or severity of methemoglobinemia can be increased when Sulthiame is combined with Cocaine.]
[L01BB02, mercaptopurine, The risk or severity of methemoglobinemia can be increased when Mercaptopurine is combined with Cocaine.]
[N06DA01, tacrine, Tacrine may increase the neuromuscular blocking activities of Cocaine.]
[J01CA15, talampicillin, The risk or severity of methemoglobinemia can be increased when Talampicillin is combined with Cocaine.]
[L02BA01, tamoxifen, The risk or severity of methemoglobinemia can be increased when Tamoxifen is combined with Cocaine.]
[N05CD07, temazepam, Temazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01CB02, teniposide, The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Cocaine.]
[R03CC03, terbutaline, Terbutaline may increase the neuromuscular blocking activities of Cocaine.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Tetracaine.]
[S03AA02, tetracycline, The risk or severity of methemoglobinemia can be increased when Tetracycline is combined with Cocaine.]
[J01DI02, ceftaroline fosamil, The risk or severity of methemoglobinemia can be increased when Ceftaroline fosamil is combined with Cocaine.]
[N05AE05, lurasidone, Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A04AD10, dronabinol, Cocaine may increase the tachycardic activities of Dronabinol.]
[N04BC07, apomorphine, Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L04AX02, thalidomide, The risk or severity of methemoglobinemia can be increased when Thalidomide is combined with Cocaine.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Cocaine.]
[L01XX41, eribulin, The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Cocaine.]
[J01BA02, thiamphenicol, The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Cocaine.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01AC01, thiotepa, The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Cocaine.]
[L01BB03, thioguanine, The risk or severity of methemoglobinemia can be increased when Tioguanine is combined with Cocaine.]
[N05CA19, thiopental, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Cocaine.]
[N05AB08, thioproperazine, Thioproperazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Cocaine.]
[N05AF04, thiothixene, Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Cocaine.]
[B02AB01, aprotinin, Aprotinin may increase the neuromuscular blocking activities of Cocaine.]
[G04BE06, moxisylyte, The serum concentration of Moxisylyte can be increased when it is combined with Cocaine.]
[N05AL03, tiapride, Tiapride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01CA13, ticarcillin, The risk or severity of methemoglobinemia can be increased when Ticarcillin is combined with Cocaine.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Cocaine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Cocaine is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Cocaine.]
[P01AB02, tinidazole, The risk or severity of methemoglobinemia can be increased when Tinidazole is combined with Cocaine.]
[S01AA12, tobramycin, The risk or severity of methemoglobinemia can be increased when Tobramycin is combined with Cocaine.]
[M03BX04, tolperisone, Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Tramadol.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Cocaine.]
[L01XF01, tretinoin, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Cocaine.]
[N05CD05, triazolam, Triazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C03AA06, trichlormethiazide, The serum concentration of Trichlormethiazide can be increased when it is combined with Cocaine.]
[A03AB12, mepenzolate, The risk or severity of adverse effects can be increased when Cocaine is combined with Mepenzolate.]
[S01EB04, demecarium, Demecarium may increase the neuromuscular blocking activities of Cocaine.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01AD02, trifluridine, The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Cocaine.]
[N05AD02, trifluperidol, Trifluperidol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AA05, triflupromazine, Triflupromazine may increase the neuromuscular blocking activities of Cocaine.]
[N04AA01, trihexyphenidyl, The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Cocaine.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Cocaine.]
[R06AD01, trimeprazine, Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AC02, trimethadione, The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Cocaine.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Cocaine is combined with Trimethaphan.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Cocaine.]
[R06AX07, triprolidine, Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03BB01, butylscopolamine, The risk or severity of adverse effects can be increased when Cocaine is combined with Butylscopolamine.]
[J01FA08, troleandomycin, The risk or severity of methemoglobinemia can be increased when Troleandomycin is combined with Cocaine.]
[N06AX24, vilazodone, Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01FA06, tropicamide, The risk or severity of adverse effects can be increased when Tropicamide is combined with Cocaine.]
[N06AX02, tryptophan, Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[M03AA02, tubocurarine, Tubocurarine may increase the neuromuscular blocking activities of Cocaine.]
[L01FX04, ipilimumab, The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Cocaine.]
[S01AA05, tyrothricin, The risk or severity of methemoglobinemia can be increased when Tyrothricin is combined with Cocaine.]
[L01EX04, vandetanib, The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Cocaine.]
[L01AD08, uracil mustard, The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Cocaine.]
[L02BX03, abiraterone, The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Cocaine.]
[J05AG05, rilpivirine, The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Cocaine.]
[A07AA12, fidaxomicin, The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Cocaine.]
[S01AA28, vancomycin, The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Cocaine.]
[N03AX21, ezogabine, The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Cocaine.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cocaine.]
[N06AX09, viloxazine, The metabolism of Cocaine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Cocaine.]
[C04AX07, vincamine, The risk or severity of methemoglobinemia can be increased when Vincamine is combined with Cocaine.]
[L01CA02, vincristine, The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Cocaine.]
[L01CA03, vindesine, The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Cocaine.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of methemoglobinemia can be increased when Levetiracetam is combined with Cocaine.]
[L01EC01, vemurafenib, The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Cocaine.]
[M05BA03, pamidronic acid, The risk or severity of methemoglobinemia can be increased when Pamidronic acid is combined with Cocaine.]
[L01FX05, brentuximab vedotin, The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Cocaine.]
[L01ED01, crizotinib, The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Cocaine.]
[L01XD05, temoporfin, The risk or severity of methemoglobinemia can be increased when Temoporfin is combined with Cocaine.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Cocaine.]
[J01MA13, trovafloxacin, The risk or severity of methemoglobinemia can be increased when Trovafloxacin is combined with Cocaine.]
[L01XX02, asparaginase, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Cocaine.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of methemoglobinemia can be increased when Alemtuzumab is combined with Cocaine.]
[L01EJ01, ruxolitinib, The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Cocaine.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Cocaine.]
[J01DH04, doripenem, The risk or severity of methemoglobinemia can be increased when Doripenem is combined with Cocaine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Cocaine.]
[L03AB11, peginterferon alfa-2a, The risk or severity of methemoglobinemia can be increased when Peginterferon alfa-2a is combined with Cocaine.]
[L01FA01, rituximab, The risk or severity of methemoglobinemia can be increased when Rituximab is combined with Cocaine.]
[J02AC03, voriconazole, The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Cocaine.]
[M03AC04, atracurium, Atracurium may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Atropine is combined with Cocaine.]
[L01XJ01, vismodegib, The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Cocaine.]
[L01EK01, axitinib, The risk or severity of methemoglobinemia can be increased when Axitinib is combined with Cocaine.]
[L01BC07, azacitidine, The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Cocaine.]
[L01BC05, gemcitabine, The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Cocaine.]
[J01CA09, azlocillin, The risk or severity of methemoglobinemia can be increased when Azlocillin is combined with Cocaine.]
[J01DF01, aztreonam, The risk or severity of methemoglobinemia can be increased when Aztreonam is combined with Cocaine.]
[R02AB04, bacitracin, The risk or severity of methemoglobinemia can be increased when Bacitracin is combined with Cocaine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Cocaine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Cocaine.]
[L01FD02, pertuzumab, The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Cocaine.]
[A08AA11, lorcaserin, Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[G04BD12, mirabegron, The risk or severity of urinary retention can be increased when Cocaine is combined with Mirabegron.]
[L01XG02, carfilzomib, The risk or severity of methemoglobinemia can be increased when Carfilzomib is combined with Cocaine.]
[L02BB04, enzalutamide, The serum concentration of Cocaine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Cocaine.]
[L01EA04, bosutinib, The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Cocaine.]
[C01CA18, octopamine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Octopamine.]
[L01EX05, regorafenib, The risk or severity of methemoglobinemia can be increased when Regorafenib is combined with Cocaine.]
[L01XL02, talimogene laherparepvec, The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Cocaine.]
[N05CA04, barbital, The risk or severity of methemoglobinemia can be increased when Barbital is combined with Cocaine.]
[J05AE04, nelfinavir, The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Cocaine.]
[L01AA09, bendamustine, The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Cocaine.]
[N04BD02, rasagiline, Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03FA09, mosapride, Mosapride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06DA02, donepezil, The therapeutic efficacy of Cocaine can be decreased when used in combination with Donepezil.]
[N03AX22, perampanel, The risk or severity of methemoglobinemia can be increased when Perampanel is combined with Cocaine.]
[N02CC03, zolmitriptan, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AC06, thonzylamine, The risk or severity of adverse effects can be increased when Cocaine is combined with Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Cocaine.]
[N01AA01, ethyl ether, Diethyl ether may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01EX07, cabozantinib, The risk or severity of methemoglobinemia can be increased when Cabozantinib is combined with Cocaine.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Cocaine.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Cocaine.]
[L01EA05, ponatinib, The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Cocaine.]
[J04AK05, bedaquiline, The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Cocaine.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Cocaine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Cocaine.]
[C03AA01, bendroflumethiazide, The serum concentration of Bendroflumethiazide can be increased when it is combined with Cocaine.]
[L04AX06, pomalidomide, The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Cocaine.]
[N05AD07, benperidol, Benperidol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01MA15, gemifloxacin, The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Cocaine.]
[S01AE07, moxifloxacin, The risk or severity of methemoglobinemia can be increased when Moxifloxacin is combined with Cocaine.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Cocaine.]
[H03AA04, tiratricol, Tiratricol may increase the vasoconstricting activities of Cocaine.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Benzocaine.]
[A10BX05, pramlintide, The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Cocaine.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Cocaine.]
[N02CC02, naratriptan, Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L04AA18, everolimus, The risk or severity of methemoglobinemia can be increased when Everolimus is combined with Cocaine.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cocaine.]
[L01EC02, dabrafenib, The serum concentration of Cocaine can be decreased when it is combined with Dabrafenib.]
[L01EE01, trametinib, The risk or severity of methemoglobinemia can be increased when Trametinib is combined with Cocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Benzyl alcohol.]
[L01EB03, afatinib, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Cocaine.]
[N06AX28, levomilnacipran, Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Bepridil.]
[L01EL01, ibrutinib, The risk or severity of methemoglobinemia can be increased when Ibrutinib is combined with Cocaine.]
[N06AX26, vortioxetine, Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AF04, eslicarbazepine, The risk or severity of methemoglobinemia can be increased when Eslicarbazepine is combined with Cocaine.]
[N03AG04, vigabatrin, The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Cocaine.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Cocaine.]
[C01CA27, droxidopa, The risk or severity of Tachycardia can be increased when Cocaine is combined with Droxidopa.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Cocaine.]
[N05CH03, tasimelteon, Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A16AA07, metreleptin, The metabolism of Cocaine can be increased when combined with Metreleptin.]
[P01CX04, miltefosine, The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Cocaine.]
[L02BG02, formestane, The risk or severity of methemoglobinemia can be increased when Formestane is combined with Cocaine.]
[A16AA06, betaine, Betaine may increase the neuromuscular blocking activities of Cocaine.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Cocaine.]
[C02CC01, bethanidine, The risk or severity of Tachycardia can be increased when Bethanidine is combined with Cocaine.]
[L04AC11, siltuximab, The risk or severity of methemoglobinemia can be increased when Siltuximab is combined with Cocaine.]
[L01ED02, ceritinib, The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Cocaine.]
[L01FG02, ramucirumab, The risk or severity of methemoglobinemia can be increased when Ramucirumab is combined with Cocaine.]
[J01XA04, dalbavancin, The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Cocaine.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cocaine.]
[J01XX11, tedizolid, The risk or severity of methemoglobinemia can be increased when Tedizolid is combined with Cocaine.]
[L01XH04, belinostat, The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Cocaine.]
[L01EM01, idelalisib, The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Cocaine.]
[N01AX05, alfaxalone, Alfaxalone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Cocaine.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Cocaine is combined with Glycopyrronium.]
[N05CM19, suvorexant, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Eliglustat.]
[L01FF02, pembrolizumab, The risk or severity of methemoglobinemia can be increased when Pembrolizumab is combined with Cocaine.]
[J01XA05, oritavancin, The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Cocaine.]
[S01AA15, dihydrostreptomycin, The risk or severity of methemoglobinemia can be increased when Dihydrostreptomycin is combined with Cocaine.]
[N05AA04, acepromazine, Acepromazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[V04CX03, methacholine, Cocaine may decrease effectiveness of Methacholine as a diagnostic agent.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Cocaine.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Cocaine is combined with Naloxegol.]
[L01BC08, decitabine, The risk or severity of methemoglobinemia can be increased when Decitabine is combined with Cocaine.]
[N04AA02, biperiden, The risk or severity of adverse effects can be increased when Biperiden is combined with Cocaine.]
[L04AX05, pirfenidone, The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Cocaine.]
[L01EX09, nintedanib, The risk or severity of methemoglobinemia can be increased when Nintedanib is combined with Cocaine.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Cocaine.]
[S03AA06, gentamicin, The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Cocaine.]
[L01FX07, blinatumomab, The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Cocaine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Cocaine.]
[L01XK01, olaparib, The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Cocaine.]
[L01FF01, nivolumab, The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Cocaine.]
[N06AX11, mirtazapine, Cocaine may increase the serotonergic activities of Mirtazapine.]
[L01EF01, palbociclib, The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Cocaine.]
[L01EX08, lenvatinib, The risk or severity of methemoglobinemia can be increased when Lenvatinib is combined with Cocaine.]
[L01XH03, panobinostat, The risk or severity of methemoglobinemia can be increased when Panobinostat is combined with Cocaine.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Cocaine.]
[L01DC01, bleomycin, The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Cocaine.]
[A03AA09, difemerine, The risk or severity of adverse effects can be increased when Cocaine is combined with Difemerine.]
[C01EB17, ivabradine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Ivabradine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Cocaine.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Cocaine is combined with Eluxadoline.]
[N05AX16, brexpiprazole, Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XJ02, sonidegib, The risk or severity of methemoglobinemia can be increased when Sonidegib is combined with Cocaine.]
[G02CX02, flibanserin, Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Cocaine.]
[N05AX15, cariprazine, Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01EC01, acetazolamide, The risk or severity of methemoglobinemia can be increased when Acetazolamide is combined with Cocaine.]
[N05AB07, acetophenazine, Acetophenazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S02AA10, acetic acid, The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Cocaine.]
[L01CX01, trabectedin, The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Cocaine.]
[L01EB04, osimertinib, The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Cocaine.]
[L01FC01, daratumumab, The risk or severity of methemoglobinemia can be increased when Daratumumab is combined with Cocaine.]
[L01EE02, cobimetinib, The risk or severity of methemoglobinemia can be increased when Cobimetinib is combined with Cocaine.]
[L01XG03, ixazomib, The risk or severity of methemoglobinemia can be increased when Ixazomib is combined with Cocaine.]
[L01FE03, necitumumab, The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Cocaine.]
[L01FX08, elotuzumab, The risk or severity of methemoglobinemia can be increased when Elotuzumab is combined with Cocaine.]
[L01ED03, alectinib, The risk or severity of methemoglobinemia can be increased when Alectinib is combined with Cocaine.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Cocaine.]
[L01XA04, satraplatin, The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Cocaine.]
[N05CA05, aprobarbital, Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AX23, brivaracetam, The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Cocaine.]
[L01XX52, venetoclax, The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Cocaine.]
[N05BA08, bromazepam, Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N04BC01, bromocriptine, Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AX08, alverine, Alverine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AB01, brompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AA19, amineptin, Amineptine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01FF05, atezolizumab, The risk or severity of methemoglobinemia can be increased when Atezolizumab is combined with Cocaine.]
[N06BX11, aniracetam, Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Cocaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Cocaine.]
[N07BC01, buprenorphine, The risk or severity of adverse effects can be increased when Cocaine is combined with Buprenorphine.]
[L02AE01, buserelin, The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Cocaine.]
[N05BE01, buspirone, Buspirone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01AB01, busulfan, The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Cocaine.]
[L01XX27, arsenic trioxide, The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Cocaine.]
[N06DA03, rivastigmine, Rivastigmine may increase the neuromuscular blocking activities of Cocaine.]
[P01BE02, artemether, The risk or severity of methemoglobinemia can be increased when Artemether is combined with Cocaine.]
[P01BE03, artesunate, The risk or severity of methemoglobinemia can be increased when Artesunate is combined with Cocaine.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Cocaine is combined with Butorphanol.]
[J01MA09, sparfloxacin, The risk or severity of methemoglobinemia can be increased when Sparfloxacin is combined with Cocaine.]
[L01FX10, olaratumab, The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Cocaine.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Cocaine.]
[S01GX07, azelastine, Azelastine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01CE04, azidocillin, The risk or severity of methemoglobinemia can be increased when Azidocillin is combined with Cocaine.]
[L01XK03, rucaparib, The risk or severity of methemoglobinemia can be increased when Rucaparib is combined with Cocaine.]
[S01AA26, azithromycin, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Cocaine.]
[J01CA06, bacampicillin, The risk or severity of methemoglobinemia can be increased when Bacampicillin is combined with Cocaine.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Cocaine.]
[L01EF02, ribociclib, The risk or severity of methemoglobinemia can be increased when Ribociclib is combined with Cocaine.]
[R03CC12, bambuterol, Bambuterol may increase the neuromuscular blocking activities of Cocaine.]
[L01FF04, avelumab, The risk or severity of methemoglobinemia can be increased when Avelumab is combined with Cocaine.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Cocaine.]
[N03AX30, beclamide, The risk or severity of methemoglobinemia can be increased when Beclamide is combined with Cocaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Cocaine.]
[R05DB01, benzonatate, The serum concentration of Cocaine can be increased when it is combined with Benzonatate.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cocaine.]
[J05AE09, tipranavir, The metabolism of Tipranavir can be decreased when combined with Cocaine.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Cocaine.]
[L01XK02, niraparib, The risk or severity of methemoglobinemia can be increased when Niraparib is combined with Cocaine.]
[L01EX10, midostaurin, The risk or severity of methemoglobinemia can be increased when Midostaurin is combined with Cocaine.]
[L01FF03, durvalumab, The risk or severity of methemoglobinemia can be increased when Durvalumab is combined with Cocaine.]
[L01ED04, brigatinib, The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Cocaine.]
[N04BD03, safinamide, Safinamide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[P01AX10, fumagillin, The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Cocaine.]
[J01MA23, delafloxacin, The risk or severity of methemoglobinemia can be increased when Delafloxacin is combined with Cocaine.]
[L01BC06, capecitabine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Cocaine.]
[L01XX59, enasidenib, The risk or severity of methemoglobinemia can be increased when Enasidenib is combined with Cocaine.]
[L01EH02, neratinib, The risk or severity of methemoglobinemia can be increased when Neratinib is combined with Cocaine.]
[L01FB01, inotuzumab ozogamicin, The risk or severity of methemoglobinemia can be increased when Inotuzumab ozogamicin is combined with Cocaine.]
[L01XH01, vorinostat, The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Cocaine.]
[L01EM02, copanlisib, The risk or severity of methemoglobinemia can be increased when Copanlisib is combined with Cocaine.]
[L01EF03, abemaciclib, The risk or severity of methemoglobinemia can be increased when Abemaciclib is combined with Cocaine.]
[R03AC17, bitolterol, The risk or severity of Tachycardia can be increased when Bitolterol is combined with Cocaine.]
[J05AG03, efavirenz, The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Cocaine.]
[J01DC10, cefprozil, The risk or severity of methemoglobinemia can be increased when Cefprozil is combined with Cocaine.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Cocaine.]
[N04AA11, bornaprine, The risk or severity of adverse effects can be increased when Cocaine is combined with Bornaprine.]
[L01BA03, raltitrexed, The risk or severity of methemoglobinemia can be increased when Raltitrexed is combined with Cocaine.]
[N05AD06, bromperidol, Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CD09, brotizolam, Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XL04, tisagenlecleucel, The risk or severity of methemoglobinemia can be increased when Tisagenlecleucel is combined with Cocaine.]
[L01XL03, axicabtagene ciloleucel, The risk or severity of methemoglobinemia can be increased when Axicabtagene ciloleucel is combined with Cocaine.]
[N05CA03, butobarbital, Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Cocaine.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Cocaine.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Cocaine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Capsaicin.]
[N05CA08, butylvinal, Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Cocaine.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Cocaine.]
[L02BB05, apalutamide, The risk or severity of methemoglobinemia can be increased when Apalutamide is combined with Cocaine.]
[N03AF01, carbamazepine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Cocaine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Cocaine.]
[A03AA03, camylofine, The risk or severity of adverse effects can be increased when Cocaine is combined with Camylofin.]
[J01CA03, carbenicillin, The risk or severity of methemoglobinemia can be increased when Carbenicillin is combined with Cocaine.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Cocaine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Cocaine.]
[N03AX24, cannabidiol, The risk or severity of methemoglobinemia can be increased when Cannabidiol is combined with Cocaine.]
[J01DE01, cefepime, The risk or severity of methemoglobinemia can be increased when Cefepime is combined with Cocaine.]
[J01DD10, cefetamet, The risk or severity of methemoglobinemia can be increased when Cefetamet is combined with Cocaine.]
[J01DD09, cefodizime, The risk or severity of methemoglobinemia can be increased when Cefodizime is combined with Cocaine.]
[J01DC11, ceforanide, The risk or severity of methemoglobinemia can be increased when Ceforanide is combined with Cocaine.]
[J01DD13, cefpodoxime, The risk or severity of methemoglobinemia can be increased when Cefpodoxime is combined with Cocaine.]
[L01EC03, encorafenib, The risk or severity of methemoglobinemia can be increased when Encorafenib is combined with Cocaine.]
[L01EE03, binimetinib, The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Cocaine.]
[J01DD14, ceftibuten, The risk or severity of methemoglobinemia can be increased when Ceftibuten is combined with Cocaine.]
[J01GB14, plazomicin, The risk or severity of methemoglobinemia can be increased when Plazomicin is combined with Cocaine.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Cocaine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Cocaine.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Ivosidenib.]
[P01BA07, tafenoquine, The risk or severity of methemoglobinemia can be increased when Tafenoquine is combined with Cocaine.]
[L01FX09, mogamulizumab, The risk or severity of methemoglobinemia can be increased when Mogamulizumab is combined with Cocaine.]
[N03AX17, stiripentol, The metabolism of Cocaine can be decreased when combined with Stiripentol.]
[J01AA13, eravacycline, The risk or severity of methemoglobinemia can be increased when Eravacycline is combined with Cocaine.]
[L01EM04, duvelisib, The risk or severity of methemoglobinemia can be increased when Duvelisib is combined with Cocaine.]
[L01FF06, cemiplimab, The risk or severity of methemoglobinemia can be increased when Cemiplimab is combined with Cocaine.]
[L01EB07, dacomitinib, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Cocaine.]
[J01AA14, sarecycline, The risk or severity of methemoglobinemia can be increased when Sarecycline is combined with Cocaine.]
[J01AA15, omadacycline, The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Cocaine.]
[S01GX12, cetirizine, Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CM04, carbromal, Carbromal may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Cocaine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, The risk or severity of adverse effects can be increased when Cocaine is combined with Chlorphenoxamine.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Cocaine.]
[L01FB02, moxetumomab pasudotox, The risk or severity of methemoglobinemia can be increased when Moxetumomab pasudotox is combined with Cocaine.]
[L01XK04, talazoparib, The risk or severity of methemoglobinemia can be increased when Talazoparib is combined with Cocaine.]
[M03BA02, carisoprodol, Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Cocaine.]
[L01ED05, lorlatinib, The risk or severity of methemoglobinemia can be increased when Lorlatinib is combined with Cocaine.]
[L01AD01, carmustine, The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Cocaine.]
[L01EX12, larotrectinib, The risk or severity of methemoglobinemia can be increased when Larotrectinib is combined with Cocaine.]
[L01EX13, gilteritinib, The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Cocaine.]
[L01XJ03, glasdegib, The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Cocaine.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Cocaine is combined with Amifampridine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Cocaine.]
[L01XX67, tagraxofusp, The risk or severity of methemoglobinemia can be increased when Tagraxofusp is combined with Cocaine.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Cocaine.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Cocaine.]
[A03FA08, cinitapride, Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[P02BX04, triclabendazole, The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Cocaine.]
[N06AX27, esketamine, Esketamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01FA09, clarithromycin, The risk or severity of methemoglobinemia can be increased when Clarithromycin is combined with Cocaine.]
[N06BA14, solriamfetol, The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Cocaine.]
[N06AX29, brexanolone, The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Cocaine.]
[L01EN01, erdafitinib, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Cocaine.]
[N05BA09, clobazam, The risk or severity of methemoglobinemia can be increased when Clobazam is combined with Cocaine.]
[J01AA11, clomocycline, The risk or severity of methemoglobinemia can be increased when Clomocycline is combined with Cocaine.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Cocaine.]
[N05BA22, cloxazolam, Cloxazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XX29, denileukin diftitox, The risk or severity of methemoglobinemia can be increased when Denileukin diftitox is combined with Cocaine.]
[L01EM03, alpelisib, The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Cocaine.]
[L01FX14, polatuzumab vedotin, The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Cocaine.]
[J01DC04, cefaclor, The risk or severity of methemoglobinemia can be increased when Cefaclor is combined with Cocaine.]
[J01DB05, cefadroxil, The risk or severity of methemoglobinemia can be increased when Cefadroxil is combined with Cocaine.]
[J01DC03, cefamandole, The risk or severity of methemoglobinemia can be increased when Cefamandole is combined with Cocaine.]
[L01XX66, selinexor, The risk or severity of methemoglobinemia can be increased when Selinexor is combined with Cocaine.]
[J01DB07, cefatrizine, The risk or severity of methemoglobinemia can be increased when Cefatrizine is combined with Cocaine.]
[J01DB04, cefazolin, The risk or severity of methemoglobinemia can be increased when Cefazolin is combined with Cocaine.]
[L02BB06, darolutamide, The risk or severity of methemoglobinemia can be increased when Darolutamide is combined with Cocaine.]
[J01CF03, methicillin, The risk or severity of methemoglobinemia can be increased when Meticillin is combined with Cocaine.]
[J01DC09, cefmetazole, The risk or severity of methemoglobinemia can be increased when Cefmetazole is combined with Cocaine.]
[J01DC06, cefonicid, The risk or severity of methemoglobinemia can be increased when Cefonicid is combined with Cocaine.]
[L01EX15, pexidartinib, The risk or severity of methemoglobinemia can be increased when Pexidartinib is combined with Cocaine.]
[J01DD12, cefoperazone, The risk or severity of methemoglobinemia can be increased when Cefoperazone is combined with Cocaine.]
[J01DD01, cefotaxime, The risk or severity of methemoglobinemia can be increased when Cefotaxime is combined with Cocaine.]
[J01DC05, cefotetan, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Cocaine.]
[N05AA06, cyamemazine, Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01DC07, cefotiam, The risk or severity of methemoglobinemia can be increased when Cefotiam is combined with Cocaine.]
[J01DC01, cefoxitin, The risk or severity of methemoglobinemia can be increased when Cefoxitin is combined with Cocaine.]
[J01DD03, cefsulodin, The risk or severity of methemoglobinemia can be increased when Cefsulodin is combined with Cocaine.]
[J01DD02, ceftazidime, The risk or severity of methemoglobinemia can be increased when Ceftazidime is combined with Cocaine.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Cocaine.]
[J01DD07, ceftizoxime, The risk or severity of methemoglobinemia can be increased when Ceftizoxime is combined with Cocaine.]
[J01DD04, ceftriaxone, The risk or severity of methemoglobinemia can be increased when Ceftriaxone is combined with Cocaine.]
[S01AA27, cefuroxime, The risk or severity of methemoglobinemia can be increased when Cefuroxime is combined with Cocaine.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01EJ02, fedratinib, The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Cocaine.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Cocaine can be decreased when it is combined with Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Cocaine.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Cocaine.]
[G04BE04, yohimbine, Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Cocaine.]
[J01XX09, daptomycin, The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Cocaine.]
[J01DB01, cephalexin, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Cocaine.]
[J01DB02, cephaloridine, The risk or severity of methemoglobinemia can be increased when Cefaloridine is combined with Cocaine.]
[J01DB03, cephalothin, The risk or severity of methemoglobinemia can be increased when Cefalotin is combined with Cocaine.]
[J01DB08, cephapirin, The risk or severity of methemoglobinemia can be increased when Cefapirin is combined with Cocaine.]
[J01DB09, cephradine, The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Cocaine.]
[L01FD01, trastuzumab, The risk or severity of methemoglobinemia can be increased when Trastuzumab is combined with Cocaine.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Cocaine.]
[L01FD04, trastuzumab deruxtecan, The risk or severity of methemoglobinemia can be increased when Trastuzumab deruxtecan is combined with Cocaine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Cocaine.]
[L01EL03, zanubrutinib, The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Cocaine.]
[N03AX25, cenobamate, The serum concentration of Cocaine can be decreased when it is combined with Cenobamate.]
[L01FX13, enfortumab vedotin, The risk or severity of methemoglobinemia can be increased when Enfortumab vedotin is combined with Cocaine.]
[R06AB06, dexbrompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Cocaine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Cocaine is combined with Dezocine.]
[L01XX10, masoprocol, The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Cocaine.]
[N05CM21, lemborexant, Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AD10, lumateperone, Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01FC02, isatuximab, The risk or severity of methemoglobinemia can be increased when Isatuximab is combined with Cocaine.]
[S01AE06, gatifloxacin, The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Cocaine.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Cocaine.]
[N02CC07, frovatriptan, Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CC04, dichloralphenazone, Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01EE04, selumetinib, The risk or severity of methemoglobinemia can be increased when Selumetinib is combined with Cocaine.]
[G03DB08, dienogest, The risk or severity of methemoglobinemia can be increased when Dienogest is combined with Cocaine.]
[A07DA04, difenoxin, Difenoxin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Cocaine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XF03, bexarotene, The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Cocaine.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Cocaine.]
[C01BD07, dronedarone, Cocaine may increase the QTc-prolonging activities of Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of methemoglobinemia can be increased when Valpromide is combined with Cocaine.]
[J01FA13, dirithromycin, The risk or severity of methemoglobinemia can be increased when Dirithromycin is combined with Cocaine.]
[L01AA02, chlorambucil, The risk or severity of methemoglobinemia can be increased when Chlorambucil is combined with Cocaine.]
[S03AA08, chloramphenicol, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Cocaine.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Cocaine.]
[N05BA02, chlordiazepoxide, Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01EN02, pemigatinib, The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Cocaine.]
[L01FX17, sacituzumab govitecan, The risk or severity of methemoglobinemia can be increased when Sacituzumab govitecan is combined with Cocaine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Cocaine.]
[A03AA08, dihexyverine, The risk or severity of adverse effects can be increased when Cocaine is combined with Dihexyverine.]
[L01EX17, capmatinib, The risk or severity of methemoglobinemia can be increased when Capmatinib is combined with Cocaine.]
[C01CA14, dopexamine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Dopexamine.]
[P01BE01, artemisinin, The risk or severity of methemoglobinemia can be increased when Artemisinin is combined with Cocaine.]
[G04BD09, trospium, The risk or severity of adverse effects can be increased when Trospium is combined with Cocaine.]
[L01EX19, ripretinib, The risk or severity of methemoglobinemia can be increased when Ripretinib is combined with Cocaine.]
[L01EX22, selpercatinib, The risk or severity of methemoglobinemia can be increased when Selpercatinib is combined with Cocaine.]
[N05CM02, chlormethiazole, The risk or severity of methemoglobinemia can be increased when Clomethiazole is combined with Cocaine.]
[M03BB02, chlormezanone, Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dyclonine is combined with Cocaine.]
[L01XX69, lurbinectedin, The risk or severity of methemoglobinemia can be increased when Lurbinectedin is combined with Cocaine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Cocaine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cocaine.]
[P01BB01, proguanil, The risk or severity of methemoglobinemia can be increased when Proguanil is combined with Cocaine.]
[N05CD14, remimazolam, Remimazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01FX12, tafasitamab, The risk or severity of methemoglobinemia can be increased when Tafasitamab is combined with Cocaine.]
[L01XL06, brexucabtagene autoleucel, The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Cocaine.]
[L01DB04, aclarubicin, The risk or severity of methemoglobinemia can be increased when Aclarubicin is combined with Cocaine.]
[L04AC19, satralizumab, The serum concentration of Cocaine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Cocaine.]
[L01EX23, pralsetinib, The risk or severity of methemoglobinemia can be increased when Pralsetinib is combined with Cocaine.]
[C03AA04, chlorothiazide, The serum concentration of Chlorothiazide can be increased when it is combined with Cocaine.]
[G03CA06, chlorotrianisene, The risk or severity of methemoglobinemia can be increased when Chlorotrianisene is combined with Cocaine.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Cocaine.]
[N05AA01, chlorpromazine, The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Cocaine.]
[N05AF03, chlorprothixene, Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01AA02, chlortetracycline, The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Cocaine.]
[C03BA04, chlorthalidone, The serum concentration of Chlorthalidone can be increased when it is combined with Cocaine.]
[M03BB03, chlorzoxazone, Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05BX03, etifoxine, Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06BX18, vinpocetine, The risk or severity of methemoglobinemia can be increased when Vinpocetine is combined with Cocaine.]
[N05BA18, ethyl loflazepate, Ethyl loflazepate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Cocaine.]
[L01BB05, fludarabine, The risk or severity of methemoglobinemia can be increased when Fludarabine is combined with Cocaine.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cocaine.]
[L01FD06, margetuximab, The risk or severity of methemoglobinemia can be increased when Margetuximab is combined with Cocaine.]
[P03AX07, abametapir, The serum concentration of Cocaine can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The risk or severity of methemoglobinemia can be increased when Tepotinib is combined with Cocaine.]
[L01EX25, umbralisib, The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Cocaine.]
[M03BA05, febarbamate, Febarbamate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AX10, felbamate, The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Cocaine.]
[N06BA08, fenozolone, The risk or severity of Tachycardia can be increased when Cocaine is combined with Fenozolone.]
[J01DD08, cefixime, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Cocaine.]
[J01DD15, cefdinir, The risk or severity of methemoglobinemia can be increased when Cefdinir is combined with Cocaine.]
[J01MB07, flumequine, The risk or severity of methemoglobinemia can be increased when Flumequine is combined with Cocaine.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Formoterol is combined with Cocaine.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Cocaine.]
[S01LA08, bevacizumab, The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Cocaine.]
[L01EK03, tivozanib, The risk or severity of methemoglobinemia can be increased when Tivozanib is combined with Cocaine.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XL07, idecabtagene vicleucel, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Cocaine.]
[L01FF07, dostarlimab, The risk or severity of methemoglobinemia can be increased when Dostarlimab is combined with Cocaine.]
[L01FX22, loncastuximab tesirine, The risk or severity of methemoglobinemia can be increased when Loncastuximab tesirine is combined with Cocaine.]
[R02AB03, fusafungin, The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Cocaine.]
[N02BF01, gabapentin, The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Cocaine.]
[N07CA02, cinnarizine, The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Cocaine.]
[J01MB06, cinoxacin, The risk or severity of methemoglobinemia can be increased when Cinoxacin is combined with Cocaine.]
[L01XX73, sotorasib, The serum concentration of Cocaine can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The risk or severity of methemoglobinemia can be increased when Infigratinib is combined with Cocaine.]
[S03AA07, ciprofloxacin, The risk or severity of methemoglobinemia can be increased when Ciprofloxacin is combined with Cocaine.]
[L01XA01, cisplatin, The risk or severity of methemoglobinemia can be increased when Cisplatin is combined with Cocaine.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Citalopram is combined with Cocaine.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Cocaine is combined with Fexinidazole.]
[L01XX74, belzutifan, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Cocaine.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Mobocertinib.]
[L01FX23, tisotumab vedotin, The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Cocaine.]
[V09AB03, ioflupane I-123, Cocaine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.]
[V09IA09, technetium Tc 99m tilmanocept, Cocaine may decrease effectiveness of Technetium Tc-99m tilmanocept as a diagnostic agent.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Clemastine is combined with Cocaine.]
[R03CC13, clenbuterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Clenbuterol.]
[J01FF01, clindamycin, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Cocaine.]
[N06AX25, St. John's wort extract, St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01EA06, asciminib, The risk or severity of methemoglobinemia can be increased when Asciminib is combined with Cocaine.]
[L02BG06, exemestane, The risk or severity of methemoglobinemia can be increased when Exemestane is combined with Cocaine.]
[L01XX75, tebentafusp, The risk or severity of methemoglobinemia can be increased when Tebentafusp is combined with Cocaine.]
[J04BA01, clofazimine, The risk or severity of methemoglobinemia can be increased when Clofazimine is combined with Cocaine.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Pacritinib is combined with Cocaine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Cocaine.]
[N03AE01, clonazepam, The risk or severity of methemoglobinemia can be increased when Clonazepam is combined with Cocaine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Cocaine.]
[C01EB24, mavacamten, The serum concentration of Cocaine can be decreased when it is combined with Mavacamten.]
[L01FX20, tremelimumab, The risk or severity of methemoglobinemia can be increased when Tremelimumab is combined with Cocaine.]
[N05AH06, clothiapine, Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05BA21, clotiazepam, Clotiazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Cocaine.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Granisetron is combined with Cocaine.]
[J01CF02, cloxacillin, The risk or severity of methemoglobinemia can be increased when Cloxacillin is combined with Cocaine.]
[L01XX77, adagrasib, The risk or severity of methemoglobinemia can be increased when Adagrasib is combined with Cocaine.]
[N05AH02, clozapine, The risk or severity of QTc prolongation can be increased when Clozapine is combined with Cocaine.]
[L01EN04, futibatinib, The risk or severity of methemoglobinemia can be increased when Futibatinib is combined with Cocaine.]
[L01FE02, panitumumab, The risk or severity of methemoglobinemia can be increased when Panitumumab is combined with Cocaine.]
[J01GB12, arbekacin, The risk or severity of methemoglobinemia can be increased when Arbekacin is combined with Cocaine.]
[N05BA13, halazepam, Halazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01EX11, quizartinib, The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Cocaine.]
[H01AC08, somatrogon, The metabolism of Cocaine can be increased when combined with Somatrogon.]
[S01AA13, fusidic acid, The risk or severity of methemoglobinemia can be increased when Fusidic acid is combined with Cocaine.]
[J01MB04, pipemidic acid, The risk or severity of methemoglobinemia can be increased when Pipemidic acid is combined with Cocaine.]
[L01XD01, porfimer sodium, The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Cocaine.]
[N07XX04, sodium oxybate, Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Cocaine is combined with Codeine.]
[J01CA18, hetacillin, The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Cocaine.]
[M03AC05, hexafluorenium, Hexafluronium may increase the neuromuscular blocking activities of Cocaine.]
[A03AB10, hexocyclium, The risk or severity of adverse effects can be increased when Cocaine is combined with Hexocyclium.]
[J01XX04, spectinomycin, The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Cocaine.]
[A03BB06, homatropine methylbromide, The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Cocaine.]
[S01FA05, homatropine, The risk or severity of adverse effects can be increased when Cocaine is combined with Homatropine.]
[J01XB01, colistin, The risk or severity of methemoglobinemia can be increased when Colistin is combined with Cocaine.]
[L01XX40, omacetaxine mepesuccinate, The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Cocaine.]
[J01DE02, cefpirome, The risk or severity of methemoglobinemia can be increased when Cefpirome is combined with Cocaine.]
[N01AB07, desflurane, Desflurane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A04AA03, tropisetron, Tropisetron may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C04AX28, ifenprodil, The risk or severity of methemoglobinemia can be increased when Ifenprodil is combined with Cocaine.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Cocaine.]
[L01BB07, nelarabine, The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Cocaine.]
[J01FA15, telithromycin, The risk or severity of methemoglobinemia can be increased when Telithromycin is combined with Cocaine.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Cocaine.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Cocaine.]
[H01AX01, pegvisomant, Pegvisomant may increase the neuromuscular blocking activities of Cocaine.]
[A03AX10, isometheptene, The risk or severity of Tachycardia can be increased when Cocaine is combined with Isometheptene.]
[N02CC05, almotriptan, Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J02AC02, itraconazole, The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Cocaine.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Emedastine is combined with Cocaine.]
[N05BA10, ketazolam, Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L02BA03, fulvestrant, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Cocaine.]
[L01EA01, imatinib, The risk or severity of methemoglobinemia can be increased when Imatinib is combined with Cocaine.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cocaine.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Cocaine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Cocaine.]
[N03AX09, lamotrigine, The risk or severity of methemoglobinemia can be increased when Lamotrigine is combined with Cocaine.]
[S01GX02, levocabastine, Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Cocaine.]
[S01AE04, lomefloxacin, The risk or severity of methemoglobinemia can be increased when Lomefloxacin is combined with Cocaine.]
[R06AX13, loratadine, Cocaine may increase the anticholinergic activities of Loratadine.]
[N05CD06, lormetazepam, Lormetazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01DC08, loracarbef, The risk or severity of methemoglobinemia can be increased when Loracarbef is combined with Cocaine.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Cocaine.]
[A03AA04, mebeverine, The risk or severity of adverse effects can be increased when Cocaine is combined with Mebeverine.]
[D10AF04, meclocycline, The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Cocaine.]
[N06AX13, medifoxamine, Medifoxamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A08AA09, mefenorex, The risk or severity of Tachycardia can be increased when Cocaine is combined with Mefenorex.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Cocaine.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Cocaine.]
[J01DH02, meropenem, The risk or severity of methemoglobinemia can be increased when Meropenem is combined with Cocaine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Adenosine is combined with Cocaine.]
[J01CA14, methampicillin, The risk or severity of methemoglobinemia can be increased when Metampicillin is combined with Cocaine.]
[N04AA03, methixene, The risk or severity of adverse effects can be increased when Metixene is combined with Cocaine.]
[R03CB02, methoxyphenamine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Methoxyphenamine.]
[R06AE03, cyclizine, Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CA10, cyclobarbital, Cyclobarbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Melperone is combined with Cocaine.]
[S01AA22, micronomicin, The risk or severity of methemoglobinemia can be increased when Micronomicin is combined with Cocaine.]
[C03AA07, cyclopenthiazide, The serum concentration of Cyclopenthiazide can be increased when it is combined with Cocaine.]
[J01FA03, midecamycin, The risk or severity of methemoglobinemia can be increased when Midecamycin is combined with Cocaine.]
[S01FA04, cyclopentolate, The risk or severity of adverse effects can be increased when Cocaine is combined with Cyclopentolate.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Cocaine.]
[N06AX07, minaprine, Minaprine may increase the neuromuscular blocking activities of Cocaine.]
[J04AB01, cycloserine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Cocaine.]
[N06AG02, moclobemide, Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AX02, cyproheptadine, Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Cocaine.]
[C02AC05, moxonidine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Moxonidine.]
[L01BC01, cytarabine, The risk or severity of methemoglobinemia can be increased when Cytarabine is combined with Cocaine.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cocaine.]
[L01AX04, dacarbazine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Cocaine.]
[L01DA01, dactinomycin, The risk or severity of methemoglobinemia can be increased when Dactinomycin is combined with Cocaine.]
[M03CA01, dantrolene, Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Cocaine.]
[L01DB02, daunorubicin, The risk or severity of methemoglobinemia can be increased when Daunorubicin is combined with Cocaine.]
[N06BX04, deanol, Deanol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Cocaine.]
[L01DB09, valrubicin, The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Cocaine.]
[A04AD11, nabilone, Cocaine may increase the tachycardic activities of Nabilone.]
[J01AA01, demeclocycline, The risk or severity of methemoglobinemia can be increased when Demeclocycline is combined with Cocaine.]
[N05BA16, nordazepam, Nordazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Cocaine.]
[N06AX06, nefazodone, Nefazodone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CM16, niaprazine, Niaprazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L02BB02, nilutamide, The risk or severity of methemoglobinemia can be increased when Nilutamide is combined with Cocaine.]
[L01FE01, cetuximab, The risk or severity of methemoglobinemia can be increased when Cetuximab is combined with Cocaine.]
[N03AG06, tiagabine, The risk or severity of methemoglobinemia can be increased when Tiagabine is combined with Cocaine.]
[M03AC11, cisatracurium, Cocaine may increase the neuromuscular blocking activities of Cisatracurium.]
[C01CA05, norfenefrine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Norfenefrine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Cocaine is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Cocaine.]
[R02AA02, dequalinium, The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Cocaine.]
[N06AA01, desipramine, The metabolism of Desipramine can be decreased when combined with Cocaine.]
[J01DH03, ertapenem, The risk or severity of methemoglobinemia can be increased when Ertapenem is combined with Cocaine.]
[L01XA03, oxaliplatin, The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Cocaine.]
[N03AF02, oxcarbazepine, The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Cocaine.]
[S03BA01, dexamethasone, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Cocaine.]
[N06BX07, oxiracetam, Oxiracetam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N04AA08, dexetimide, The risk or severity of adverse effects can be increased when Cocaine is combined with Dexetimide.]
[G04BD04, oxybutynin, The risk or severity of adverse effects can be increased when Cocaine is combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Cocaine.]
[A03AA01, oxyphencyclimine, The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Cocaine.]
[L01EB01, gefitinib, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Cocaine.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Cocaine.]
[R05DA09, dextromethorphan, Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AC01, paramethadione, The risk or severity of methemoglobinemia can be increased when Paramethadione is combined with Cocaine.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Cocaine is combined with Dextromoramide.]
[N06AB05, paroxetine, Paroxetine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Cocaine is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of methemoglobinemia can be increased when Diazepam is combined with Cocaine.]
[N03AX07, phenacemide, The risk or severity of methemoglobinemia can be increased when Phenacemide is combined with Cocaine.]
[J01CE05, phenethicillin, The risk or severity of methemoglobinemia can be increased when Pheneticillin is combined with Cocaine.]
[S01AA29, dibekacin, The risk or severity of methemoglobinemia can be increased when Dibekacin is combined with Cocaine.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Phenol.]
[N03AD02, phensuximide, The risk or severity of methemoglobinemia can be increased when Phensuximide is combined with Cocaine.]
[N06AA08, dibenzepin, Dibenzepin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cinchocaine is combined with Cocaine.]
[J01CF01, dicloxacillin, The risk or severity of methemoglobinemia can be increased when Dicloxacillin is combined with Cocaine.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Cocaine.]
[A03AA07, dicyclomine, The risk or severity of adverse effects can be increased when Dicyclomine is combined with Cocaine.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Cocaine.]
[N05AD05, pipamperone, Pipamperone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AB14, pipenzolate, The risk or severity of adverse effects can be increased when Cocaine is combined with Pipenzolate.]
[L01DC04, ixabepilone, The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Cocaine.]
[L01EB02, erlotinib, The risk or severity of methemoglobinemia can be increased when Erlotinib is combined with Cocaine.]
[L01DB08, pirarubicin, The risk or severity of methemoglobinemia can be increased when Pirarubicin is combined with Cocaine.]
[R03CC07, pirbuterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Pirbuterol.]
[P02CB02, diethylcarbamazine, Diethylcarbamazine may increase the neuromuscular blocking activities of Cocaine.]
[A08AA03, diethylpropion, Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C08CA03, isradipine, The risk or severity of QTc prolongation can be increased when Isradipine is combined with Cocaine.]
[A03AB11, poldine, The risk or severity of adverse effects can be increased when Cocaine is combined with Poldine.]
[C01AA04, digitoxin, The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Cocaine.]
[C01AA05, digoxin, The risk or severity of QTc prolongation can be increased when Digoxin is combined with Cocaine.]
[L01XX24, pegaspargase, The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Cocaine.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Cocaine is combined with Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of methemoglobinemia can be increased when Lenalidomide is combined with Cocaine.]
[J05AE08, atazanavir, The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Cocaine.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Cocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Pramocaine.]
[C08DB01, diltiazem, The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Cocaine.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Cocaine.]
[M03BX03, pridinol, Pridinol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AB03, dimethindene, The risk or severity of adverse effects can be increased when Cocaine is combined with Dimetindene.]
[R03CC08, procaterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Procaterol.]
[N03AG05, progabide, The risk or severity of methemoglobinemia can be increased when Progabide is combined with Cocaine.]
[J01CE03, propicillin, The risk or severity of methemoglobinemia can be increased when Propicillin is combined with Cocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Proparacaine is combined with Cocaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Cocaine is combined with Diphenoxylate.]
[N05CD10, quazepam, Quazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AA23, quinupramine, Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Cisapride is combined with Cocaine.]
[S01XA23, sirolimus, The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Cocaine.]
[N05AL04, remoxipride, Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R03CC14, reproterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Reproterol.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Cocaine.]
[N07AA03, distigmine, Distigmine may increase the neuromuscular blocking activities of Cocaine.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Cocaine.]
[S02AA12, rifamycin SV, The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Cocaine.]
[J04AB05, rifapentine, The risk or severity of methemoglobinemia can be increased when Rifapentine is combined with Cocaine.]
[D06AX11, rifaximin, The risk or severity of methemoglobinemia can be increased when Rifaximin is combined with Cocaine.]
[N07XX02, riluzole, The risk or severity of methemoglobinemia can be increased when Riluzole is combined with Cocaine.]
[N05AX08, risperidone, Risperidone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AE09, levocetirizine, Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Cocaine.]
[J01MB01, rosoxacin, The risk or severity of methemoglobinemia can be increased when Rosoxacin is combined with Cocaine.]
[L01EX01, sunitinib, The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Cocaine.]
[L01XG01, bortezomib, The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Cocaine.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Cocaine.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Cocaine.]
[C01CA07, dobutamine, The risk or severity of Tachycardia can be increased when Dobutamine is combined with Cocaine.]
[A03FA03, domperidone, The therapeutic efficacy of Domperidone can be decreased when used in combination with Cocaine.]
[C01CA04, dopamine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Cocaine.]
[N06AA12, doxepin, Doxepin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Cocaine.]
[L01DB01, doxorubicin, The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Cocaine.]
[J01AA02, doxycycline, The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Cocaine.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AB06, sertraline, Sertraline may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N01AB08, sevoflurane, Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Cocaine.]
[A08AA10, sibutramine, Sibutramine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Cocaine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Cocaine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Cocaine.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Sultopride is combined with Cocaine.]
[N02CC01, sumatriptan, Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[V04CX07, edrophonium, Edrophonium may increase the neuromuscular blocking activities of Cocaine.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Talinolol is combined with Cocaine.]
[J01MA05, temafloxacin, The risk or severity of methemoglobinemia can be increased when Temafloxacin is combined with Cocaine.]
[J01CA17, temocillin, The risk or severity of methemoglobinemia can be increased when Temocillin is combined with Cocaine.]
[L01AX03, temozolomide, The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Cocaine.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Terodiline.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Cocaine.]
[S01GA02, tetrahydrozoline, The risk or severity of Tachycardia can be increased when Cocaine is combined with Tetryzoline.]
[M03BX07, tetrazepam, Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[M03BX05, thiocolchicoside, Thiocolchicoside may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AB05, thiopropazate, Thiopropazate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[G04BD01, emepronium, Emepronium may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AX14, tianeptine, Tianeptine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05BA23, tofisopam, Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AG03, toloxatone, Toloxatone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Cocaine.]
[N03AX11, topiramate, The risk or severity of hyperthermia and oligohydrosis can be increased when Cocaine is combined with Topiramate.]
[L02BA02, toremifene, The risk or severity of methemoglobinemia can be increased when Toremifene is combined with Cocaine.]
[J01AA12, tigecycline, The risk or severity of methemoglobinemia can be increased when Tigecycline is combined with Cocaine.]
[R01AA09, tramazoline, The risk or severity of Tachycardia can be increased when Cocaine is combined with Tramazoline.]
[L01AB02, treosulfan, The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Cocaine.]
[N05CD11, triazulenone, Loprazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CM07, triclofos, Triclofos may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AB08, tridihexethyl, The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Cocaine.]
[H02CA01, trilostane, The risk or severity of methemoglobinemia can be increased when Trilostane is combined with Cocaine.]
[R06AA10, trimethobenzamide, Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L02AE04, triptorelin, The risk or severity of methemoglobinemia can be increased when Triptorelin is combined with Cocaine.]
[L01AA07, trofosfamide, The risk or severity of methemoglobinemia can be increased when Trofosfamide is combined with Cocaine.]
[N04AA12, tropatepine, The risk or severity of adverse effects can be increased when Cocaine is combined with Tropatepine.]
[R03CC11, tulobuterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Tulobuterol.]
[N01AB04, enflurane, Enflurane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02CA06, urapidil, Urapidil may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01MA04, enoxacin, The risk or severity of methemoglobinemia can be increased when Enoxacin is combined with Cocaine.]
[N05AL06, veralipride, Veralipride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01CA04, vinorelbine, The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Cocaine.]
[S01FB02, ephedrine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Ephedrine.]
[S01GX10, epinastine, Epinastine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Venlafaxine.]
[C01CX07, xamoterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Xamoterol.]
[S01GA03, xylometazoline, The risk or severity of Tachycardia can be increased when Cocaine is combined with Xylometazoline.]
[S01EA01, epinephrine, The risk or severity of Tachycardia can be increased when Epinephrine is combined with Cocaine.]
[L01DB03, epirubicin, The risk or severity of methemoglobinemia can be increased when Epirubicin is combined with Cocaine.]
[N05CF02, zolpidem, Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AX15, zonisamide, The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Cocaine.]
[N05CF01, zopiclone, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AX11, zotepine, Zotepine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XA02, carboplatin, The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Cocaine.]
[C02AC02, guanfacine, Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01BG01, moricizine, Moricizine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[G02AB03, ergonovine, Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02CA02, ergotamine, Ergotamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01AA17, erythromycin, The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Cocaine.]
[N05CD04, estazolam, The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Cocaine.]
[L01XX11, estramustine, The risk or severity of methemoglobinemia can be increased when Estramustine is combined with Cocaine.]
[J04AK02, ethambutol, The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Cocaine.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Cocaine.]
[C01CA15, gepefrine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Gepefrine.]
[N05CM08, ethchlorvynol, Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J04AD03, ethionamide, The risk or severity of methemoglobinemia can be increased when Ethionamide is combined with Cocaine.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Cocaine.]
[L01AG01, ethoglucid, The risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Cocaine.]
[N04AA05, profenamine, Profenamine may increase the neuromuscular blocking activities of Cocaine.]
[N03AD01, ethosuximide, The risk or severity of methemoglobinemia can be increased when Ethosuximide is combined with Cocaine.]
[N03AB01, ethotoin, The risk or severity of methemoglobinemia can be increased when Ethotoin is combined with Cocaine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Meloxicam is combined with Cocaine.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Cocaine is combined with Ethylmorphine.]
[C01CA01, etilefrine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Etilefrine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01CB01, etoposide, The risk or severity of methemoglobinemia can be increased when Etoposide is combined with Cocaine.]
[N05AE03, sertindole, Sertindole may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Cocaine.]
[L04AD02, tacrolimus, The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Cocaine.]
[A02BA04, nizatidine, Nizatidine may increase the neuromuscular blocking activities of Cocaine.]
[J01MA08, fleroxacin, The risk or severity of methemoglobinemia can be increased when Fleroxacin is combined with Cocaine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Cocaine.]
[R06AX12, terfenadine, The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Cocaine.]
[P01AX07, trimetrexate, The risk or severity of methemoglobinemia can be increased when Trimetrexate is combined with Cocaine.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Cocaine.]
[N06AB08, fluvoxamine, Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Cocaine.]
[R01AX06, mupirocin, The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Cocaine.]
[L02AE02, leuprolide, The risk or severity of methemoglobinemia can be increased when Leuprolide is combined with Cocaine.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Cocaine.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Felodipine is combined with Cocaine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Fendiline is combined with Cocaine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Fenfluramine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Cocaine is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Cocaine is combined with Fentanyl.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Cocaine.]
[L01BB06, clofarabine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Cocaine.]
[L04AA40, cladribine, The risk or severity of methemoglobinemia can be increased when Cladribine is combined with Cocaine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Cocaine.]
[G04BD02, flavoxate, The risk or severity of adverse effects can be increased when Cocaine is combined with Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Cocaine.]
[J01CF05, floxacillin, The risk or severity of methemoglobinemia can be increased when Flucloxacillin is combined with Cocaine.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Cocaine.]
[N07CA03, flunarizine, The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Cocaine.]
[N05CD03, flunitrazepam, Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AA14, melitracen, Melitracen may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[V03AZ01, ethanol, Ethanol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01BC09, floxuridine, The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Cocaine.]
[L01BC02, fluorouracil, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Cocaine.]
[N06AB03, fluoxetine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Cocaine.]
[N05AB02, fluphenazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CD01, flurazepam, Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Cocaine.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Cocaine.]
[S02AA17, fosfomycin, The risk or severity of methemoglobinemia can be increased when Fosfomycin is combined with Cocaine.]
[S01AA07, framycetin, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Cocaine.]
[L01BC03, tegafur, The risk or severity of methemoglobinemia can be increased when Tegafur is combined with Cocaine.]
[N06BX17, adrafinil, The risk or severity of Tachycardia can be increased when Cocaine is combined with Adrafinil.]
[M03AA01, alcuronium, Alcuronium may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[G01AX06, furazolidone, Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CF04, eszopiclone, Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AL05, amisulpride, Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06DA04, galantamine, Galantamine may increase the neuromuscular blocking activities of Cocaine.]
[M03AC02, gallamine, Gallamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Cocaine.]
[N03AA04, barbexaclone, The risk or severity of methemoglobinemia can be increased when Barbexaclone is combined with Cocaine.]
[N06AX08, bifemelane, Bifemelane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01XA03, telavancin, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Cocaine.]
[L02BX02, degarelix, The risk or severity of methemoglobinemia can be increased when Degarelix is combined with Cocaine.]
[L01EA02, dasatinib, The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Cocaine.]
[N04BC06, cabergoline, The risk or severity of methemoglobinemia can be increased when Cabergoline is combined with Cocaine.]
[N03AD03, methsuximide, The risk or severity of methemoglobinemia can be increased when Methsuximide is combined with Cocaine.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Cocaine is combined with Alfentanil.]
[L01EH01, lapatinib, The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Cocaine.]
[H04AA01, glucagon, Cocaine may increase the gastrointestinal motility reducing activities of Glucagon.]
[N05CM18, dexmedetomidine, The risk or severity of seizure can be decreased when Dexmedetomidine is combined with Cocaine.]
[N05CE01, glutethimide, Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Cocaine.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Cocaine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Cocaine.]
[H01AB01, thyrotropin alfa, Thyrotropin alfa may increase the vasoconstricting activities of Cocaine.]
[L01EX02, sorafenib, The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Cocaine.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Cocaine.]
[R02AB30, gramicidin, The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Cocaine.]
[L02AE03, goserelin, The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Cocaine.]
[P01BX01, halofantrine, The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Cocaine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Haloperidol.]
[N01AB01, halothane, Halothane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Cocaine.]
[N05AH04, quetiapine, The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Cocaine.]
[N02CX03, iprazochrome, Iprazochrome may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01CE02, irinotecan, The risk or severity of methemoglobinemia can be increased when Irinotecan is combined with Cocaine.]
[N05CA21, allobarbital, Allobarbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C09CA01, losartan, The risk or severity of QTc prolongation can be increased when Losartan is combined with Cocaine.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Cocaine.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Cocaine.]
[L01XX03, altretamine, The risk or severity of methemoglobinemia can be increased when Altretamine is combined with Cocaine.]
[N05CA16, hexobarbital, The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Cocaine.]
[R03CC05, hexoprenaline, The risk or severity of Tachycardia can be increased when Cocaine is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Cocaine.]
[C08CA10, nilvadipine, The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Cocaine.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Cocaine.]
[C02DB02, hydralazine, The therapeutic efficacy of Hydralazine can be decreased when used in combination with Cocaine.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Cocaine.]
[R05DA03, hydrocodone, The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Cocaine.]
[C03AA02, hydroflumethiazide, The serum concentration of Hydroflumethiazide can be increased when it is combined with Cocaine.]
[G04BD06, propiverine, The risk or severity of adverse effects can be increased when Cocaine is combined with Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Cocaine.]
[N05AX07, prothipendyl, Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Cocaine.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Hydroxyzine.]
[J04AB04, rifabutin, The risk or severity of methemoglobinemia can be increased when Rifabutin is combined with Cocaine.]
[C02AC06, rilmenidine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Rilmenidine.]
[L01DB06, idarubicin, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Cocaine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Cocaine.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Cocaine.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Cocaine is combined with Sufentanil.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Cocaine.]
[L01CD01, paclitaxel, The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Cocaine.]
[J01XA02, teicoplanin, The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Cocaine.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Cocaine.]
[M03BX02, tizanidine, The risk or severity of methemoglobinemia can be increased when Tizanidine is combined with Cocaine.]
[L01CE01, topotecan, The risk or severity of methemoglobinemia can be increased when Topotecan is combined with Cocaine.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Indapamide is combined with Cocaine.]
[L03AB04, interferon alfa-2a, The risk or severity of methemoglobinemia can be increased when Interferon alfa-2a is combined with Cocaine.]
[L03AB05, interferon alfa-2b, The risk or severity of methemoglobinemia can be increased when Interferon alfa-2b is combined with Cocaine.]
[N06AX17, milnacipran, Milnacipran may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AA30, piperidolate, The risk or severity of adverse effects can be increased when Cocaine is combined with Piperidolate.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Articaine.]
[N05BA12, alprazolam, Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CH02, ramelteon, Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Cocaine.]
[L01XX35, anagrelide, The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Cocaine.]
[C07AA01, alprenolol, Alprenolol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C03BA02, quinethazone, The serum concentration of Quinethazone can be increased when it is combined with Cocaine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Cocaine.]
[N06AA13, iprindole, Iprindole may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AF05, iproniazid, Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AA07, chlorproethazine, Chlorproethazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[P01AX06, atovaquone, The risk or severity of methemoglobinemia can be increased when Atovaquone is combined with Cocaine.]
[R03CC06, isoetharine, The risk or severity of Tachycardia can be increased when Isoetharine is combined with Cocaine.]
[N01AB06, isoflurane, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01EB07, isoflurophate, Isoflurophate may increase the neuromuscular blocking activities of Cocaine.]
[N04BX02, entacapone, Entacapone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J04AC01, isoniazid, The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Cocaine.]
[R03CB01, isoproterenol, Isoprenaline may increase the neuromuscular blocking activities of Cocaine.]
[C04AA01, isoxsuprine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Isoxsuprine.]
[J01FA07, josamycin, The risk or severity of methemoglobinemia can be increased when Josamycin is combined with Cocaine.]
[N06AX18, reboxetine, Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01AA24, kanamycin, The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Cocaine.]
[N01AX03, ketamine, Ketamine may increase the neuromuscular blocking activities of Cocaine.]
[C02KD01, ketanserin, Ketanserin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J02AB02, ketoconazole, The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Cocaine.]
[N05AH03, olanzapine, Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Cocaine.]
[C01CA22, arbutamine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Arbutamine.]
[N04BC09, rotigotine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01MB02, nalidixic acid, The risk or severity of methemoglobinemia can be increased when Nalidixic acid is combined with Cocaine.]
[C07AG01, labetalol, The therapeutic efficacy of Labetalol can be decreased when used in combination with Cocaine.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Cocaine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Cocaine.]
[N07AA30, ambenonium, Ambenonium may increase the neuromuscular blocking activities of Cocaine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Cocaine.]
[N03AX18, lacosamide, The risk or severity of methemoglobinemia can be increased when Lacosamide is combined with Cocaine.]
[J01CA11, amdinocillin, The risk or severity of methemoglobinemia can be increased when Amdinocillin is combined with Cocaine.]
[J01CA08, amdinocillin pivoxil, The risk or severity of methemoglobinemia can be increased when Pivmecillinam is combined with Cocaine.]
[L01DC03, mitomycin, The risk or severity of methemoglobinemia can be increased when Mitomycin is combined with Cocaine.]
[N04BA01, levodopa, The absorption of Levodopa can be decreased when combined with Cocaine.]
[S02DA01, lidocaine, The risk or severity of seizure can be increased when Lidocaine is combined with Cocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Cocaine.]
[J01FF02, lincomycin, The risk or severity of methemoglobinemia can be increased when Lincomycin is combined with Cocaine.]
[S01AA21, amikacin, The risk or severity of methemoglobinemia can be increased when Amikacin is combined with Cocaine.]
[N02CA07, lisuride, Lisuride may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AA07, lofepramine, Lofepramine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01AD02, lomustine, The risk or severity of methemoglobinemia can be increased when Lomustine is combined with Cocaine.]
[A07DA03, loperamide, The risk or severity of QTc prolongation can be increased when Loperamide is combined with Cocaine.]
[N05BA06, lorazepam, The risk or severity of methemoglobinemia can be increased when Lorazepam is combined with Cocaine.]
[N05AH01, loxapine, Loxapine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01AA04, lymecycline, The risk or severity of methemoglobinemia can be increased when Lymecycline is combined with Cocaine.]
[L01EG01, temsirolimus, The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Cocaine.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Cocaine.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Cocaine.]
[V04CC02, magnesium sulfate, The risk or severity of methemoglobinemia can be increased when Magnesium sulfate is combined with Cocaine.]
[L01BA05, pralatrexate, The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Cocaine.]
[L01EA03, nilotinib, The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Cocaine.]
[N06AA21, maprotiline, Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A08AA05, mazindol, Mazindol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Cocaine.]
[L01AA05, mechlorethamine, The risk or severity of methemoglobinemia can be increased when Mechlorethamine is combined with Cocaine.]
[R06AE05, meclizine, Meclizine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05BA03, medazepam, The risk or severity of methemoglobinemia can be increased when Medazepam is combined with Cocaine.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Cocaine.]
[P01BC02, mefloquine, The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Cocaine.]
[J01FG01, pristinamycin, The risk or severity of methemoglobinemia can be increased when Pristinamycin is combined with Cocaine.]
[N05CH01, melatonin, Melatonin may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01AA03, melphalan, The risk or severity of methemoglobinemia can be increased when Melphalan is combined with Cocaine.]
[N06DX01, memantine, Memantine may increase the neuromuscular blocking activities of Cocaine.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Cocaine is combined with Meperidine.]
[C01CA11, mephentermine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Mephentermine.]
[N03AB04, mephenytoin, The risk or severity of methemoglobinemia can be increased when Mephenytoin is combined with Cocaine.]
[N03AA01, mephobarbital, The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Cocaine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Mepivacaine.]
[N05BC01, meprobamate, Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Cocaine is combined with Meptazinol.]
[L02BG01, aminoglutethimide, The risk or severity of methemoglobinemia can be increased when Aminoglutethimide is combined with Cocaine.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Cocaine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Paliperidone.]
[C01CA09, metaraminol, The risk or severity of Tachycardia can be increased when Metaraminol is combined with Cocaine.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Cocaine.]
[H01CB03, lanreotide, The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Cocaine.]
[J01AA05, methacycline, The risk or severity of methemoglobinemia can be increased when Metacycline is combined with Cocaine.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Cocaine is combined with Methadone.]
[N06BA03, methamphetamine, Metamfetamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AB07, methantheline, The risk or severity of adverse effects can be increased when Cocaine is combined with Methantheline.]
[R06AC05, methapyrilene, Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CM01, methaqualone, Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AA30, metharbital, The risk or severity of methemoglobinemia can be increased when Metharbital is combined with Cocaine.]
[L01XD04, aminolevulinic acid, The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Cocaine.]
[J01XX05, methenamine, The risk or severity of methemoglobinemia can be increased when Methenamine is combined with Cocaine.]
[G02CB05, metergoline, Metergoline may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01BA04, pemetrexed, The risk or severity of methemoglobinemia can be increased when Pemetrexed is combined with Cocaine.]
[M03BA03, methocarbamol, Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CA15, methohexital, The risk or severity of methemoglobinemia can be increased when Methohexital is combined with Cocaine.]
[N02BG08, ziconotide, Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L04AX03, methotrexate, The risk or severity of methemoglobinemia can be increased when Methotrexate is combined with Cocaine.]
[N05AA02, methotrimeprazine, Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01CA10, methoxamine, The risk or severity of Tachycardia can be increased when Methoxamine is combined with Cocaine.]
[N02BG09, methoxyflurane, Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C03AA08, methyclothiazide, The serum concentration of Methyclothiazide can be increased when it is combined with Cocaine.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Cocaine.]
[V04CG05, methylene blue, Cocaine may increase the serotonergic activities of Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Cocaine.]
[N03AF03, rufinamide, The risk or severity of methemoglobinemia can be increased when Rufinamide is combined with Cocaine.]
[G03EK01, methyltestosterone, The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Cocaine.]
[N05CE02, methyprylon, Methyprylon may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02CA04, methysergide, Methysergide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Metoclopramide is combined with Cocaine.]
[C03BA08, metolazone, The serum concentration of Metolazone can be increased when it is combined with Cocaine.]
[C07AB02, metoprolol, The metabolism of Metoprolol can be decreased when combined with Cocaine.]
[P01AB01, metronidazole, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Cocaine.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Cocaine.]
[J01CA10, mezlocillin, The risk or severity of methemoglobinemia can be increased when Mezlocillin is combined with Cocaine.]
[N06AX03, mianserin, Mianserin may increase the anticholinergic activities of Cocaine.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Cocaine.]
[N05CD08, midazolam, Midazolam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01CA17, midodrine, The risk or severity of Tachycardia can be increased when Midodrine is combined with Cocaine.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Cocaine.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Cocaine.]
[J01AA08, minocycline, The risk or severity of methemoglobinemia can be increased when Minocycline is combined with Cocaine.]
[J01FA11, miocamycin, The risk or severity of methemoglobinemia can be increased when Miocamycin is combined with Cocaine.]
[L01DC02, plicamycin, The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Cocaine.]
[L01AX01, mitobronitol, The risk or severity of methemoglobinemia can be increased when Mitobronitol is combined with Cocaine.]
[L01XX23, mitotane, The risk or severity of methemoglobinemia can be increased when Mitotane is combined with Cocaine.]
[L01DB07, mitoxantrone, The risk or severity of methemoglobinemia can be increased when Mitoxantrone is combined with Cocaine.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Cocaine.]
[L03AA03, molgramostim, The risk or severity of methemoglobinemia can be increased when Molgramostim is combined with Cocaine.]
[N05AE02, molindone, Molindone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L03AC01, aldesleukin, The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Cocaine.]
[C01BD01, amiodarone, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Cocaine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Cocaine is combined with Morphine.]
[A04AA05, palonosetron, Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01DD06, moxalactam, The risk or severity of methemoglobinemia can be increased when Latamoxef is combined with Cocaine.]
[L04AA52, ofatumumab, The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Cocaine.]
[L01EX03, pazopanib, The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Cocaine.]
[L04AA06, mycophenolic acid, The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Cocaine.]
[M03AC03, vecuronium, Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CA02, amobarbital, The risk or severity of methemoglobinemia can be increased when Amobarbital is combined with Cocaine.]
[P01BA06, amodiaquine, The risk or severity of methemoglobinemia can be increased when Amodiaquine is combined with Cocaine.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Cocaine.]
[N03AB05, fosphenytoin, The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Cocaine.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Cocaine.]
[J01CA04, amoxicillin, The risk or severity of methemoglobinemia can be increased when Amoxicillin is combined with Cocaine.]
[J01CF06, nafcillin, The risk or severity of methemoglobinemia can be increased when Nafcillin is combined with Cocaine.]
[C04AX21, nafronyl, Naftidrofuryl may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Cocaine is combined with Nalbuphine.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Cocaine is combined with Naltrexone.]
[S01GA01, naphazoline, The risk or severity of Tachycardia can be increased when Cocaine is combined with Naphazoline.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Cocaine.]
[N06AX21, duloxetine, Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S01AA10, natamycin, The risk or severity of methemoglobinemia can be increased when Natamycin is combined with Cocaine.]
[N04BX01, tolcapone, Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01CD02, docetaxel, The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Cocaine.]
[L02BG04, letrozole, The risk or severity of methemoglobinemia can be increased when Letrozole is combined with Cocaine.]
[S03AA01, neomycin, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Cocaine.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Cocaine is combined with Remifentanil.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Cocaine.]
[S01EB06, neostigmine, Neostigmine may increase the neuromuscular blocking activities of Cocaine.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of methemoglobinemia can be increased when Amphotericin B is combined with Cocaine.]
[S01AA19, ampicillin, The risk or severity of methemoglobinemia can be increased when Ampicillin is combined with Cocaine.]
[S01AA23, netilmicin, The risk or severity of methemoglobinemia can be increased when Netilmicin is combined with Cocaine.]
[N06AX23, desvenlafaxine, Desvenlafaxine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XX01, amsacrine, The risk or severity of methemoglobinemia can be increased when Amsacrine is combined with Cocaine.]
[N06AF02, nialamide, Nialamide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C08CA04, nicardipine, The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Cocaine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Cocaine.]
[N07BA01, nicotine, The risk or severity of Tachycardia can be increased when Nicotine is combined with Cocaine.]
[C08CA05, nifedipine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Cocaine.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Cocaine.]
[N05CD02, nitrazepam, The risk or severity of methemoglobinemia can be increased when Nitrazepam is combined with Cocaine.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Cocaine.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Cocaine.]
[N05CF03, zaleplon, The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Cocaine.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N06AX04, nomifensine, Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01CA03, norepinephrine, The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Cocaine.]
[S01AE02, norfloxacin, The risk or severity of methemoglobinemia can be increased when Norfloxacin is combined with Cocaine.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Cocaine.]
[G02CA02, nylidrin, The risk or severity of Tachycardia can be increased when Cocaine is combined with Nylidrin.]
[H01CB02, octreotide, The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Cocaine.]
[S02AA16, ofloxacin, The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Cocaine.]
[J01FA05, oleandomycin, The risk or severity of methemoglobinemia can be increased when Oleandomycin is combined with Cocaine.]
[N06AA05, opipramol, Opipramol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Cocaine is combined with Opium.]
[R03CB03, metaproterenol, The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Cocaine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Cocaine.]
[J01CF04, oxacillin, The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Cocaine.]
[N05BA04, oxazepam, Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01MB05, oxolinic acid, The risk or severity of methemoglobinemia can be increased when Oxolinic acid is combined with Cocaine.]
[C07AA02, oxprenolol, Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Cocaine is combined with Oxycodone.]
[C01DX03, oxyfedrine, The risk or severity of Tachycardia can be increased when Cocaine is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The risk or severity of Tachycardia can be increased when Cocaine is combined with Oxymetazoline.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Cocaine is combined with Oxymorphone.]
[N05AE01, oxypertine, Oxypertine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AB03, oxyphenonium, The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cocaine.]
[S01AA04, oxytetracycline, The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Cocaine.]
[H01BB02, oxytocin, The risk or severity of hypertension can be increased when Cocaine is combined with Oxytocin.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Cocaine.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Asenapine.]
[N02AX06, tapentadol, The risk or severity of adverse effects can be increased when Cocaine is combined with Tapentadol.]
[M03AC01, pancuronium, Pancuronium may increase the neuromuscular blocking activities of Cocaine.]
[J04AB30, capreomycin, The risk or severity of methemoglobinemia can be increased when Capreomycin is combined with Cocaine.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Papaverine is combined with Cocaine.]
[N05CC05, paraldehyde, The risk or severity of methemoglobinemia can be increased when Paraldehyde is combined with Cocaine.]
[C02KC01, pargyline, Pargyline may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A07AA06, paromomycin, The risk or severity of methemoglobinemia can be increased when Paromomycin is combined with Cocaine.]
[J01MA03, pefloxacin, The risk or severity of methemoglobinemia can be increased when Pefloxacin is combined with Cocaine.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Cocaine.]
[C07AA23, penbutolol, Penbutolol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Cocaine.]
[S01AA14, penicillin G, The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Cocaine.]
[J01CE09, penicillin G procaine, The risk or severity of methemoglobinemia can be increased when Procaine benzylpenicillin is combined with Cocaine.]
[J01CE02, penicillin V, The risk or severity of methemoglobinemia can be increased when Phenoxymethylpenicillin is combined with Cocaine.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Cocaine is combined with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Cocaine.]
[L01XX08, pentostatin, The risk or severity of methemoglobinemia can be increased when Pentostatin is combined with Cocaine.]
[N05AB10, perazine, Perazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N04BC02, pergolide, Pergolide may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Cocaine.]
[L01FX01, edrecolomab, The risk or severity of methemoglobinemia can be increased when Edrecolomab is combined with Cocaine.]
[N05AB03, perphenazine, Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Cocaine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Cocaine is combined with Phenazocine.]
[N06AF03, phenelzine, Phenelzine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Cocaine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Cocaine.]
[N03AA02, phenobarbital, The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Cocaine.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Cocaine.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Cocaine is combined with Phenoperidine.]
[A08AA01, phentermine, The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Cocaine.]
[S01GA05, phenylephrine, The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Cocaine.]
[R01BA01, phenylpropanolamine, The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Cocaine.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Cocaine.]
[L01XF02, alitretinoin, The risk or severity of methemoglobinemia can be increased when Alitretinoin is combined with Cocaine.]
[S01AE08, besifloxacin, The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Cocaine.]
[S01AE05, levofloxacin, The risk or severity of methemoglobinemia can be increased when Levofloxacin is combined with Cocaine.]
[V03AB19, physostigmine, Physostigmine may increase the neuromuscular blocking activities of Cocaine.]
[L02BB03, bicalutamide, The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Cocaine.]
[C08CX01, mibefradil, The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Cocaine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Cocaine.]
[C07AA03, pindolol, Pindolol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01CA12, piperacillin, The risk or severity of methemoglobinemia can be increased when Piperacillin is combined with Cocaine.]
[J05AE01, saquinavir, The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Cocaine.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Cocaine.]
[L01AX02, pipobroman, The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Cocaine.]
[N05AC04, pipothiazine, Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A02BX03, pirenzepine, The risk or severity of adverse effects can be increased when Pirenzepine is combined with Cocaine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Cocaine is combined with Piritramide.]
[J01DD16, cefditoren, The risk or severity of methemoglobinemia can be increased when Cefditoren is combined with Cocaine.]
[J01MA11, grepafloxacin, The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Cocaine.]
[J01CA02, pivampicillin, The risk or severity of methemoglobinemia can be increased when Pivampicillin is combined with Cocaine.]
[N02CX01, pizotyline, Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J05AG02, delavirdine, The metabolism of Delavirdine can be decreased when combined with Cocaine.]
[N05CA22, proxibarbal, Proxibarbal may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L02BG03, anastrozole, The risk or severity of methemoglobinemia can be increased when Anastrozole is combined with Cocaine.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Cocaine.]
[A03AE01, alosetron, Alosetron may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[S03AA03, polymyxin B, The risk or severity of methemoglobinemia can be increased when Polymyxin B is combined with Cocaine.]
[C03AA05, polythiazide, The serum concentration of Polythiazide can be increased when it is combined with Cocaine.]
[J05AE03, ritonavir, The serum concentration of Cocaine can be increased when it is combined with Ritonavir.]
[B05XA01, potassium chloride, The risk or severity of gastrointestinal ulceration can be increased when Cocaine is combined with Potassium chloride.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Cocaine.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Cocaine.]
[N05BA11, prazepam, Prazepam may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01AA08, prednimustine, The risk or severity of methemoglobinemia can be increased when Prednimustine is combined with Cocaine.]
[S03BA02, prednisolone, The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Cocaine.]
[H02AB07, prednisone, The risk or severity of methemoglobinemia can be increased when Prednisone is combined with Cocaine.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Antazoline is combined with Cocaine.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Cocaine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Prilocaine is combined with Cocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Primaquine is combined with Cocaine.]
[N03AA03, primidone, The risk or severity of methemoglobinemia can be increased when Primidone is combined with Cocaine.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Probucol is combined with Cocaine.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Cocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Cocaine.]
[L01XB01, procarbazine, The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Cocaine.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Cocaine.]
[N04AA04, procyclidine, The risk or severity of adverse effects can be increased when Procyclidine is combined with Cocaine.]
[N05AA03, promazine, The risk or severity of QTc prolongation can be increased when Promazine is combined with Cocaine.]
[R06AD02, promethazine, Promethazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C01BC03, propafenone, The risk or severity of QTc prolongation can be increased when Propafenone is combined with Cocaine.]
[N01AX04, propanidid, Propanidid may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[A03AB05, propantheline, The risk or severity of adverse effects can be increased when Propantheline is combined with Cocaine.]
[N05AC01, periciazine, Periciazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CM06, propiomazine, Propiomazine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[L01XH02, romidepsin, The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Cocaine.]
[N01AX10, propofol, Propofol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Cocaine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, Propranolol may increase the vasoconstricting activities of Cocaine.]
[N02CC04, rizatriptan, Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J04AD01, prothionamide, The risk or severity of methemoglobinemia can be increased when Protionamide is combined with Cocaine.]
[N06AA11, protriptyline, Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[R01BA02, pseudoephedrine, The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Cocaine.]
[N05AX12, aripiprazole, Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Cocaine is combined with Dalfampridine.]
[A03AB15, diphemanil, The risk or severity of adverse effects can be increased when Cocaine is combined with Diphemanil.]
[A03AB09, isopropamide, The risk or severity of adverse effects can be increased when Cocaine is combined with Isopropamide.]
[S01FA03, methscopolamine, The risk or severity of adverse effects can be increased when Cocaine is combined with Methscopolamine.]
[N05CA07, talbutal, Talbutal may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CA09, vinbarbital, Vinbarbital may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05BB02, captodiamine, Captodiame may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[M03BA04, styramate, Styramate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[P02CC01, pyrantel, Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J04AK01, pyrazinamide, The risk or severity of methemoglobinemia can be increased when Pyrazinamide is combined with Cocaine.]
[N07AA02, pyridostigmine, Pyridostigmine may increase the neuromuscular blocking activities of Cocaine.]
[R06AC01, pyrilamine, Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[P01BD01, pyrimethamine, The risk or severity of methemoglobinemia can be increased when Pyrimethamine is combined with Cocaine.]
[P01AX05, quinacrine, The risk or severity of methemoglobinemia can be increased when Quinacrine is combined with Cocaine.]
[C01BA01, quinidine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Cocaine.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Cocaine.]
[C02AA02, reserpine, Reserpine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J04AB02, rifampin, The risk or severity of methemoglobinemia can be increased when Rifampicin is combined with Cocaine.]
[R03AC05, rimiterol, The risk or severity of Tachycardia can be increased when Cocaine is combined with Rimiterol.]
[G02CA01, ritodrine, The risk or severity of Tachycardia can be increased when Ritodrine is combined with Cocaine.]
[N06AX01, 5-hydroxytryptophan, Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[J01AA09, rolitetracycline, The risk or severity of methemoglobinemia can be increased when Rolitetracycline is combined with Cocaine.]
[J01FA06, roxithromycin, The risk or severity of methemoglobinemia can be increased when Roxithromycin is combined with Cocaine.]
[A07EC01, sulfasalazine, The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Cocaine.]
[S01FA02, scopolamine, Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N05CA06, secobarbital, The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Cocaine.]
[V04CK01, secretin, The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Cocaine.]
[L01FA03, obinutuzumab, The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Cocaine.]
[D06BA01, silver sulfadiazine, The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Cocaine.]
[J01GB08, sisomicin, The risk or severity of methemoglobinemia can be increased when Sisomicin is combined with Cocaine.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Cocaine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Cocaine.]
[L01CD04, cabazitaxel, The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Cocaine.]
[J01FA02, spiramycin, The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Cocaine.]
[N05CC01, chloral hydrate, Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Cocaine.]
[L01CD03, paclitaxel poliglumex, The risk or severity of methemoglobinemia can be increased when Paclitaxel poliglumex is combined with Cocaine.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Cocaine is combined with Ipratropium.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[N06DA02, donepezil, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[S01AA26, azithromycin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[P01BA01, chloroquine, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AD08, droperidol, QT prolonging agents - QT prolonging agents]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[C01BD01, amiodarone, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[C01BA01, quinidine, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
